Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

317.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 291,193
  • Market Cap: £317.50m
  • RiskGrade: 125

Dividend Data

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 89.54 139.99 142.80 87.73 64.06
Operating Profit/(Loss) (184.17) (30.22) 20.77 (5.69) (14.47)
Net Interest (4.35) (15.76) (0.89) (0.88) (6.42)
Profit Before Tax (188.53) (45.98) 19.88 (6.57) (20.89)
Profit After Tax (184.16) (45.16) 19.01 (6.24) (16.07)
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD (184.16) (45.16) 19.01 (6.24) (16.07)
Attributable to:          
Equity Holders of Parent Company (157.49) (39.16) 19.01 (6.24) (16.07)
Minority Interests (26.67) (6.00) n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic (163.11p) (41.29p) 22.77p (7.81p) (22.10p)
Earnings per Share - Diluted (163.11p) (41.29p) 22.20p (7.81p) (22.10p)
Earnings per Share - Adjusted (163.11p) (41.29p) 22.77p (7.81p) (22.10p)
Continuing and Discontinued EPS          
Earnings per Share - Basic (163.11p) (41.29p) 22.77p (7.81p) (22.10p)
Earnings per Share - Diluted (163.11p) (41.29p) 22.20p (7.81p) (22.10p)
Earnings per Share - Adjusted (163.11p) (41.29p) 22.77p (7.81p) (22.10p)
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 75.69 133.78 69.73 72.30 61.93
Intangible Assets 30.98 105.89 0.05 0.07 0.10
Investment Properties n/a n/a n/a n/a n/a
Investments n/a n/a n/a n/a n/a
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 4.34 5.01 3.61 3.61 3.96
  111.01 244.68 73.39 75.98 65.99
Current Assets          
Inventories 12.87 12.62 9.52 6.91 2.58
Trade & Other Receivables 24.74 61.59 44.75 53.93 30.05
Cash at Bank & in Hand 103.72 141.29 108.94 46.74 16.24
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets n/a n/a 0.63 0.37 8.07
  141.33 215.50 163.84 107.95 56.94
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 252.34 460.18 237.23 183.93 122.93
           
Liabilities          
Current Liabilities          
Borrowings 3.65 3.30 0.85 4.47 0.48
Other Current Liabilities 40.66 56.37 32.45 47.98 28.46
  44.31 59.66 33.31 52.45 28.94
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 107.80 110.99 8.49 9.37 7.91
Provisions 7.71 14.01 6.24 5.84 5.45
Other Non-Current Liabilities 14.68 39.33 1.85 3.52 5.01
  130.19 164.32 16.58 18.73 18.36
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 174.51 223.99 49.89 71.18 47.30
           
Net Assets 77.83 236.19 187.34 112.75 75.63
           
Capital & Reserves          
Share Capital 48.40 48.13 43.09 41.16 38.42
Share Premium Account 380.33 379.95 307.77 258.02 222.62
Other Reserves (1.81) (24.89) 2.29 2.29 2.29
Retained Earnings (352.92) (198.54) (165.81) (188.72) (187.70)
Shareholders Funds 74.01 204.65 187.34 112.75 75.63
           
Minority Interests/Other Equity 3.83 31.54 n/a n/a n/a
Total Equity 77.83 236.19 187.34 112.75 75.63
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities (28.52) (12.61) 25.45 3.12 (3.51)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities 2.81 (56.46) (9.46) (10.80) (19.40)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (12.70) 98.62 46.21 38.19 6.91
Net Increase/Decrease In Cash (38.41) 29.55 62.20 30.50 (16.00)
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted n/a n/a 54.0 n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 89.54p 139.99p 1.44p 109.74p 88.10p
Pre-Tax Profit per Share (188.53p) (45.98p) 0.20p (8.22p) (28.73p)
Operating Margin (205.69%) (21.59%) 14.54% (6.49%) (22.59%)
Return on Capital Employed n/a n/a 0.10% n/a n/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted n/a n/a 5,351.5 n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share (28.52p) (12.62p) 25.45p 3.90p (4.83p)
Cash Incr/Decr per Share (38.41p) 29.55p 0.63p 38.15p (22.01p)
Net Asset Value per Share (exc. Intangibles) 46.85p 130.31p 187.28p 140.94p 103.89p
Net Gearing 10.46% -13.20% -53.17% -29.18% -10.38%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page